These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6487516)

  • 21. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells.
    Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y
    Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia.
    Inaba M; Sakurai Y
    Cancer Lett; 1979 Dec; 8(2):111-5. PubMed ID: 555868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.
    Ramu A; Fridkin M; Steinherz R
    Cancer Chemother Pharmacol; 1985; 15(1):31-4. PubMed ID: 4006047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
    Capranico G; Dasdia T; Zunino F
    Int J Cancer; 1986 Feb; 37(2):227-31. PubMed ID: 3943921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells.
    Radel S; Fredericks W; Mayhew E; Baker R
    Cancer Chemother Pharmacol; 1990; 25(4):241-6. PubMed ID: 1967228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative cytotoxicities of various morpholinyl anthracyclines.
    Streeter DG; Taylor DL; Acton EM; Peters JH
    Cancer Chemother Pharmacol; 1985; 14(2):160-4. PubMed ID: 3971481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T; Iida H; Nojiri M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1983 Jun; 43(6):2905-10. PubMed ID: 6850602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophoretic mobility studies on doxorubicin-resistant and -sensitive murine P388 leukemic cells.
    Nair S; Horton A; Leif RC; Krishan A
    Cytometry; 1988 May; 9(3):232-7. PubMed ID: 3163971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple fluorometric method to discriminate adriamycin-resistant subline from adriamycin-sensitive parental P388 murine leukemia cell line.
    Dekker K; Kojima N; Yamamoto S; Tatsumi K; Mino M; Yagi K
    Biochem Int; 1987 Jun; 14(6):997-1001. PubMed ID: 3453100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
    Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
    Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of doxorubicin (adriamycin) in resistant P388 mouse leukemia cells.
    Ganapathi R; Grabowski D; Turinic R; Valenzuela R
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):799-806. PubMed ID: 6540180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Augmentation of pirarubicin cytotoxicity by chlorpromazine in doxorubicin-resistant mouse P388 leukemia cells].
    Shibata H; Sano F; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
    Yakugaku Zasshi; 1990 Sep; 110(9):678-81. PubMed ID: 2262880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of doxorubicin-induced DNA lesions by verapamil, DMDP and dipyridamole in resistant P388 cell lines.
    Yin MB; Bankusli I; Frank C; Rustum YM
    Anticancer Res; 1990; 10(2A):327-32. PubMed ID: 2346306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probing membrane alterations associated with anthracycline resistance using fluorescent dyes.
    Kessel D
    Biochem Pharmacol; 1988 Nov; 37(22):4253-6. PubMed ID: 3196354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
    Ramu A; Shan TC; Glaubiger D
    Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential agglutination of P388 adriamycin-sensitive and P388 adriamycin-resistant leukemia cells.
    Basrur VS; Chitnis MP; Menon RS
    Oncology; 1983; 40(3):202-4. PubMed ID: 6843944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of cellular lipids in doxorubicin-sensitive and -resistant P388 mouse leukemia cells.
    Holleran WM; DeGregorio MW; Ganapathi R; Wilbur JR; Macher BA
    Cancer Chemother Pharmacol; 1986; 17(1):11-5. PubMed ID: 3698172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizine.
    Jaffrézou JP; Levade T; Chatelain P; Laurent G
    Cancer Res; 1992 Dec; 52(23):6440-6. PubMed ID: 1423291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verapamil effect on the accumulation of doxorubicin in the leukemia P388 cells with induced antibiotic resistance.
    Moroz LV; Donenko FV; Borovkova NB; Sitdikova SM
    Arch Geschwulstforsch; 1990; 60(2):129-32. PubMed ID: 2339961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.